Back to today’s briefing

Story perspectives

Flawed Studies Threaten Mifepristone's Safety Amid Abortion Debate

5/31/2025

45 4

Left

Opponents Question Mifepristone

Abortion opponents are leveraging questionable studies to cast doubt on the safety of mifepristone, a vital abortion medication. Critics point out serious flaws in these studies, which clash with years of evidence affirming the drug's safety. As federal officials contemplate a review of mifepristone's approval, fears grow over possible new restrictions in the ongoing battle for reproductive rights in the U.S.

Center

Texas Republicans' Abortion Setback

Texas Republicans experienced a setback as their bill, SB 2880, aimed at restricting abortion pills, failed to secure a House vote. This proposed legislation sought to enable private lawsuits against distributors but was met with concerns over its constitutionality. With public support for stringent abortion measures dwindling, the path ahead for similar legislation appears increasingly challenging.

1 of 2

Opponents Question Mifepristone

Abortion opponents are leveraging questionable studies to cast doubt on the safety of mifepristone, a vital abortion medication. Critics point out serious flaws in these studies, which clash with years of evidence affirming the drug's safety. As federal officials contemplate a review of mifepristone's approval, fears grow over possible new restrictions in the ongoing battle for reproductive rights in the U.S.

1 / 2